ADAM9 and neoplasm: In agreement with these studies, B16F1 cell proliferation in vivo in tumors from ADAM9 deficient mice exhibited higher proliferation at the tumor periphery, in close vicinity to areas with high collagen density as compared to tumors from WT control mice [15].